Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Dec 26 2025
Jul 30 2026
May 9 2026
Dec 1 2025
Mar 26 2026